AstraZeneca Worries Complicate Bid to Vaccinate the World Bloomberg 2 hrs ago James Paton, Tim Loh and Todd Gillespie
(Bloomberg) Growing worries that AstraZeneca Plc’s Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul.
Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on in a bid to end the pandemic.
Safety concerns could shake confidence in the injection, even though regulators reiterated that its benefits outweigh the risks. Many regions are turning their attention to vaccines from Johnson & Johnson and developers in China, Russia and elsewhere, but they’re still in a difficult position with demand for doses far outstripping supply.
AstraZeneca Worries Complicate Bid to Vaccinate the World
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Robert Jenrick announces public inquiry into Cumbria s controversial coal mine
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
A UK holiday park refused bookings from people with certain surnames to stop Traveller and Gypsy families staying there
wigantoday.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wigantoday.net Daily Mail and Mail on Sunday newspapers.